December 9, 2024 - 20:53

While lab-grown diamonds have flourished among Gen Z, De Beers has found success for grown gems elsewhere. The company has shifted its focus from traditional luxury jewelry to innovative applications in various industries. This strategic pivot has opened up exciting new avenues for growth, showcasing the versatility of lab-grown diamonds.
One of the most promising areas is in the technology sector, where these diamonds are being utilized in high-performance electronics and advanced optics. Their unique properties make them ideal for enhancing the efficiency and durability of electronic devices. Additionally, the use of lab-grown diamonds in industrial applications, such as cutting tools and abrasives, is gaining traction due to their superior hardness and cost-effectiveness.
As consumer preferences evolve, De Beers is capitalizing on the growing acceptance of lab-grown diamonds, not just as a luxury item but as a practical and sustainable alternative. This shift reflects a broader trend towards sustainability and innovation, positioning the company for continued success in a rapidly changing market.
May 16, 2026 - 00:10
Blake's Snow Shack owned by man with Down syndrome in Texas turns 10In the small North Texas town of Sanger, a beloved local business is marking a sweet anniversary. Blake`s Snow Shack, a shaved ice stand owned and operated by a man with Down syndrome, is turning...
May 15, 2026 - 04:31
SBA Launches Small Business Pitch Competition » CBIAThe U.S. Small Business Administration has announced a new pitch competition aimed at companies that show strong innovation and have a track record of using SBA-backed financing tools. The contest...
May 14, 2026 - 01:02
INOVIO Reports First Quarter 2026 Financial Results and Recent Business HighlightsINOVIO has released its financial results for the first quarter of 2026, alongside a summary of recent business developments. The company`s primary focus remains on the regulatory path for its lead...
May 13, 2026 - 04:15
Curis Provides First Quarter 2026 Business UpdateCuris, Inc., a biotechnology company advancing the development of its lead drug candidate emavusertib, provided a business update for the first quarter of 2026. The company is focused on...